Economic Case for Pharmacare - Steve Morgan

The Economic Case for Universal Pharmacare

Dr. Steve Morgan

The World Health Organization has declared that all nations are obligated to ensure equitable access to necessary medicines through pharmaceutical policies that work in conjunction with broader systems of universal health coverage. To that end, every developed country with a universal health care system provides universal coverage of prescription drugs—except Canada.  Canadians deserve universal and equitable access to necessary medicines. Universal, comprehensive, public “Pharmacare”—working in conjunction with our universal “Medicare” system—is the best way to achieve this at a fair and affordable cost to patients and society as a whole.

Join Dr. Morgan in a webinar to discuss this key policy issue on September 21st at 1 p.m. Toronto Time.

Biographical Notes

Steve Morgan is a Professor of health policy in the School of Population and Public Health (UBC). An expert in pharmaceutical policy, Dr. Morgan’s research helps governments balance three sometimes-competing goals: providing equitable access to necessary medicines, managing health care spending responsibly, and providing incentive for valued innovation. Dr. Morgan has published over 100 peer-reviewed research papers on pharmaceutical policies. He has advised governments in Canada and abroad and has produced work for the World Health Organization and the Organization for Economic Cooperation and Development.

Dr. Morgan earned degrees in economics from the University of Western Ontario, Queen’s University, and the University of British Columbia. He received post-doctoral training in health care policy at McMaster University and UBC and numerous career awards.